Indivior PLC (INDV) Receives Average Rating of “Buy” from Analysts
Shares of Indivior PLC (LON:INDV) have earned a consensus recommendation of “Buy” from the six research firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is GBX 395.50 ($5.33).
A number of research firms have commented on INDV. Jefferies Group LLC lifted their price objective on shares of Indivior PLC from GBX 490 ($6.61) to GBX 540 ($7.28) and gave the company a “buy” rating in a research note on Friday, August 11th. Royal Bank Of Canada restated an “outperform” rating and issued a GBX 470 ($6.34) price objective on shares of Indivior PLC in a research note on Thursday, August 3rd. Numis Securities Ltd restated a “buy” rating and issued a GBX 490 ($6.61) price objective on shares of Indivior PLC in a research note on Tuesday, July 11th. Citigroup Inc. reiterated a “neutral” rating and set a GBX 280 ($3.78) price target on shares of Indivior PLC in a research note on Tuesday, September 5th. Finally, Stifel Nicolaus reiterated a “buy” rating and set a GBX 400 ($5.39) price target on shares of Indivior PLC in a research note on Friday, September 15th.
COPYRIGHT VIOLATION WARNING: This news story was first published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/09/23/indivior-plc-indv-receives-average-rating-of-buy-from-analysts.html.
Shares of Indivior PLC (LON INDV) traded up 2.85% during midday trading on Friday, reaching GBX 325.10. The company’s stock had a trading volume of 2,353,354 shares. Indivior PLC has a 52 week low of GBX 246.50 and a 52 week high of GBX 421.50. The stock’s market capitalization is GBX 2.34 billion. The company has a 50 day moving average of GBX 367.14 and a 200-day moving average of GBX 335.73.
About Indivior PLC
Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence (the Indivior Business). Its treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue and central nervous system (CNS) disorders/schizophrenia.
Receive News & Ratings for Indivior PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior PLC and related companies with MarketBeat.com's FREE daily email newsletter.